Phase II trial evaluating the use of 21-gene recurrence score (RS) to select preoperative therapy in hormone receptor (HR)-positive breast cancer.

Authors

null

Amelia Bruce Zelnak

The Winship Cancer Institute of Emory University, Atlanta, GA

Amelia Bruce Zelnak , Sujatha Murali , Toncred Marya Styblo , Grant Walter Carlson , Sheryl G. A. Gabram , Monica Rizzo , Mylin Ann Torres , Mary Newell , Yuan Liu , Ruth O'Regan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

ER+

Clinical Trial Registration Number

NCT00941330, NCT00832338

Citation

J Clin Oncol 31, 2013 (suppl; abstr 562)

DOI

10.1200/jco.2013.31.15_suppl.562

Abstract #

562

Poster Bd #

4A

Abstract Disclosures